Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Ocular Complications of Diabetes and Therapeutic Approaches

Vieira-Potter VJ., Karamichos D., Lee DJ.

Narrative Review on Systemic / IV, published in Biomed Res Int (2016) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Biomed Res Int (2016)
Reported sample size
—
Source database
Europe PMC
PMID
27119078
PMCID
PMC4826913
DOI
10.1155/2016/3801570
Citations
101

Abstract (original English)

Diabetes mellitus (DM) is a metabolic disease defined by elevated blood glucose (BG). DM is a global epidemic and the prevalence is anticipated to continue to increase. The ocular complications of DM negatively impact the quality of life and carry an extremely high economic burden. While systemic control of BG can slow the ocular complications they cannot stop them, especially if clinical symptoms are already present. With the advances in biodegradable polymers, implantable ocular devices can slowly release medication to stop, and in some cases reverse, diabetic complications in the eye. In this review we discuss the ocular complications associated with DM, the treatments available with a focus on localized treatments, and what promising treatments are on the horizon.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
EyeHumansGlaucomaDiabetic RetinopathyDiabetes ComplicationsInsulinBlood GlucoseRisk FactorsQuality of LifeMacular Edema

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research